VOYA Investment Management
NRIX icon

VOYA Investment Management’s Nurix Therapeutics NRIX Stock Holding History

VOYA Investment Management’s Portfolio NRIX Stock Details NRIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$450K Sell
18,534
-18,253
-50% -$311K ﹤0.01% 1881
2026
Q1 		$570K Sell
36,787
-172
-0.5% -$2.85K ﹤0.01% 1668
2025
Q4 		$701K Buy
36,959
+22,837
+162% +$328K ﹤0.01% 1617
2025
Q3 		$130K Sell
14,122
-6,592
-32% -$68.5K ﹤0.01% 2259
2025
Q2 		$236K Buy
20,714
+1,291
+7% +$14K ﹤0.01% 2259
2025
Q1 		$231K Sell
19,423
-35,656
-65% -$596K ﹤0.01% 2244
2024
Q4 		$1.04M Buy
55,079
+34,811
+172% +$798K ﹤0.01% 1578
2024
Q3 		$455K Buy
20,268
+83
+0.4% +$1.88K ﹤0.01% 2044
2024
Q2 		$421K Buy
20,185
+4,200
+26% +$65.4K ﹤0.01% 2095
2024
Q1 		$235K Sell
15,985
-22,471
-58% -$242K ﹤0.01% 2383
2023
Q4 		$397K Buy
38,456
+5,486
+17% +$37.6K ﹤0.01% 2193
2023
Q3 		$259K Buy
32,970
+2,898
+10% +$26.5K ﹤0.01% 2389
2023
Q2 		$300K Buy
30,072
+12,041
+67% +$123K ﹤0.01% 2367
2023
Q1 		$160K Hold
18,031
– – ﹤0.01% 2600
2022
Q4 		$198K Hold
18,031
– – ﹤0.01% 2576
2022
Q3 		$235K Buy
18,031
+1,158
+7% +$18.3K ﹤0.01% 2500
2022
Q2 		$214K Buy
16,873
+4,647
+38% +$52.7K ﹤0.01% 2361
2022
Q1 		$171K Hold
12,226
– – ﹤0.01% 2409
2021
Q4 		$354K Sell
12,226
-132
-1% -$4K ﹤0.01% 2206
2021
Q3 		$370K Hold
12,358
– – ﹤0.01% 2223
2021
Q2 		$328K Buy
12,358
+1,917
+18% +$56.3K ﹤0.01% 2333
2021
Q1 		$325K Buy
+10,441
New +$395K ﹤0.01% 2280

Other funds holding NRIX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

VOYA Investment Management's NRIX Position: Q2 2026 in Review

VOYA Investment Management reduced its Nurix Therapeutics (NRIX) stake by 50% in Q2 2026, selling an estimated $311K and leaving 18,534 shares worth $450K. The position accounts for ﹤0.01% of the portfolio, ranked #1881.

VOYA Investment Management first reported a position in NRIX in Q1 2021 and has held it in 22 quarters since. The position peaked at $1.04M in Q4 2024. 211 funds tracked by Wall St. Rank hold NRIX as of Q2 2026.

  • VOYA Investment Management held 18,534 shares of Nurix Therapeutics worth $450K as of Q2 2026.
  • VOYA Investment Management sold 18,253 Nurix Therapeutics shares in Q2 2026, an estimated $311K.
  • Nurix Therapeutics made up ﹤0.01% of VOYA Investment Management's portfolio in Q2 2026, its #1881 holding.
  • VOYA Investment Management first reported a position in Nurix Therapeutics in Q1 2021 and has held it in 22 quarters since.
  • VOYA Investment Management's Nurix Therapeutics position peaked at $1.04M in Q4 2024.
  • 211 funds tracked by Wall St. Rank held Nurix Therapeutics as of Q2 2026.

Based on VOYA Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.